263 related articles for article (PubMed ID: 29149593)
1. NOTCH2 Hajdu-Cheney Mutations Escape SCF
Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
[TBL] [Abstract][Full Text] [Related]
2. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
Canalis E; Zanotti S
Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678
[TBL] [Abstract][Full Text] [Related]
3. Hajdu-Cheney syndrome: a review.
Canalis E; Zanotti S
Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
[TBL] [Abstract][Full Text] [Related]
4. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
5. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
6. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
[TBL] [Abstract][Full Text] [Related]
7. Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome.
Stathopoulos IP; Trovas G; Lampropoulou-Adamidou K; Koromila T; Kollia P; Papaioannou NA; Lyritis G
Bone; 2013 Jan; 52(1):366-71. PubMed ID: 23117206
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
9. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
10. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
11. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
12. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome.
Majewski J; Schwartzentruber JA; Caqueret A; Patry L; Marcadier J; Fryns JP; Boycott KM; Ste-Marie LG; McKiernan FE; Marik I; Van Esch H; ; Michaud JL; Samuels ME
Hum Mutat; 2011 Oct; 32(10):1114-7. PubMed ID: 21681853
[TBL] [Abstract][Full Text] [Related]
13. Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.
Zhao W; Petit E; Gafni RI; Collins MT; Robey PG; Seton M; Miller KK; Mannstadt M
Osteoporos Int; 2013 Aug; 24(8):2275-81. PubMed ID: 23389697
[TBL] [Abstract][Full Text] [Related]
14. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
[TBL] [Abstract][Full Text] [Related]
15. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
[TBL] [Abstract][Full Text] [Related]
16. Hajdu-Cheney syndrome with atypical cardiovascular abnormalities.
Ekure EN; Sokunbi O; Kruszka P; Muenke M; Adeyemo AA
Am J Med Genet A; 2023 Jan; 191(1):271-274. PubMed ID: 36301051
[TBL] [Abstract][Full Text] [Related]
17. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.
Isidor B; Le Merrer M; Exner GU; Pichon O; Thierry G; Guiochon-Mantel A; David A; Cormier-Daire V; Le Caignec C
Hum Mutat; 2011 Nov; 32(11):1239-42. PubMed ID: 21793104
[TBL] [Abstract][Full Text] [Related]
18. Phenotype variability in Hajdu-Cheney syndrome.
Regev M; Pode-Shakked B; Jacobson JM; Raas-Rothschild A; Goldstein DB; Anikster Y
Eur J Med Genet; 2019 Jan; 62(1):35-38. PubMed ID: 29698804
[TBL] [Abstract][Full Text] [Related]
19. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis.
Isidor B; Lindenbaum P; Pichon O; Bézieau S; Dina C; Jacquemont S; Martin-Coignard D; Thauvin-Robinet C; Le Merrer M; Mandel JL; David A; Faivre L; Cormier-Daire V; Redon R; Le Caignec C
Nat Genet; 2011 Mar; 43(4):306-8. PubMed ID: 21378989
[TBL] [Abstract][Full Text] [Related]
20. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
Yu J; Schilling L; Eller T; Canalis E
J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
